Commentary Open Access
Commentary: Expanding the Understanding of Gut Microbial Dysbiosis in Alzheimer’s Disease
Sonam Kumari1,*, Mohit Kumar1
- 1Indian Council of Medical Research, New Delhi, India
Corresponding Author
Sonam Kumari, sonam.kumari92@icmr.gov.in, sonam.icmr19@gmail.com
Received Date: March 15, 2026
Accepted Date: June 18, 2026
Kumari S, Kumar M. Expanding the Understanding of Gut Microbial Dysbiosis in Alzheimer’s Disease. J Exp Neurol. 2026;7(2):90–92.
Copyright: © 2026 Kumari S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Autism – A Potential Autoimmune Disease Neurodegeneration-Induced Autoantibodies against Neural Proteins
We hypothesize that maternal neurodegeneration, resulting from a chemical, infectious or physical brain injury event, can be causative in the development of autism spectrum disorders (ASD). Following a maternal brain injury event before or during gestation, maternal neural proteins escape the breached blood brain barrier (BBB), triggering the formation of IgG autoantibodies.
Neuroprotective Effects of Khaya Anthotheca (Welw.) C.DC (Meliaceae) Decoction on Neurodegeneration Induced by Estrogen Depletion in Rats
The cortex, hippocampus, and amygdala are among the brain regions where estrogens may act to improve cognition, memory and mood. In these regions, estrogens have many beneficial effects, including neuroprotection, neurogenesis, as well as neurotrophic, antioxidant, and anti-inflammatory effects [1-2].
Neurodegeneration, Fall Risk, and Emergency Department Care: Emerging Evidence
Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are increasingly recognized as key contributors to fall risk among older adults. Falls are the leading cause of injury-related emergency visits among the elderly, and cognitive decline appears to play a bidirectional role in this relationship.
Monoamine Oxidase B in Astrocytic GABA Synthesis: A Central Mechanism in Neurodegeneration and Neuroinflammation
Monoamine oxidase B (MAO-B) is a mitochondrial enzyme predominantly expressed in astrocytes, where it plays a crucial role in neurotransmitter metabolism, oxidative stress regulation, and neuroinflammation. In addition to its well-characterized function in the oxidative deamination of monoamines such as dopamine, noradrenaline, and serotonin, MAO-B is increasingly recognized for its involvement in astrocytic GABA synthesis.